Answers are grounded in this paper and cite their sources.
The present study aimed at investigating of frequency of polymorphism of interleukin-2 gene (IL2) at position+166 SNP) in Type 1 Diabetes and in healthy controls subjects 39 of Iraqi patients, (12 males & 27 females;1 5.65 ± 1.79 years) and 21 controls.(7 mail & 14 female ; 14.66 ± 3.43 years) attended the hospital in Baghdad for diagnosis and treatment during the period February 2015 – January 2016 were enrolled in this study, the polymorphism of IL2+166 was data waved by polymerase chain reaction-specific sequence primer (PCR-SSP) assay. The results showed a comparison IL2+166 genotypes & alleles between T1D patients & controls frequencies of TT genotype & T allele (71.69vs. 68.95%;P =0.589 respectively) There was a significant increase in patients contrast to controls, (51.38vs. 48.08%; P =0.312) and associated RR rates were 19.2% & 27.0%, respectively. And the related EF values were 1.56 & 1.60 .Similar observations were made in GG genotype. In contrast TG genotype & G allele (23.93 vs. 28.55%,P =1.000 respectively) Low frequency was observed in patients compared to healthy subjects (43.28 vs. 43.22%; P =0.312), and the related PF values were 0.56 & 0.62 , respectively. The results of the study indicate that IL2+166 SNP may have a role in the mechanism of etiopathogenic of T1D in the samples of Iraqi patients
No takes yet. Share an insight, caveat, or question.
B. Hassan Ibtesam (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: